Syringe exchange programs: Impact on injection drug users and the role of the pharmacist from a U.S. perspective
Authors:
- Alkiviadis G. NacopoulosANAlkiviadis G. Nacopoulos
- Andrea J. LewtasALAndrea J. Lewtas
- Maria M. OusterhoutMOMaria M. Ousterhout
- 1 March 2010
- journal article
- review article
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 50 (2) , 148-157
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994–2004Preventive Medicine, 2009
- Who Purchases Nonprescription Syringes? Characterizing Customers of the Expanded Syringe Access Program (ESAP)Journal of Urban Health, 2009
- Needle Exchange and Sexual Risk Behaviors Among a Cohort of Injection Drug Users in Chicago, IllinoisSexually Transmitted Diseases, 2009
- Greater Drug Injecting Risk for HIV, HBV, and HCV Infection in a City Where Syringe Exchange and Pharmacy Syringe Distribution are IllegalJournal of Urban Health, 2008
- Hospital- Versus Community–Based Syringe Exchange: A Randomized Controlled TrialAIDS Education and Prevention, 2007
- Increased Access to Unrestricted Pharmacy Sales of Syringes in Seattle–King County, Washington: Structural and Individual-Level Changes, 1996 Versus 2003American Journal of Public Health, 2006
- Injection Risk Behavior among Women Syringe Exchangers in San FranciscoSubstance Use & Misuse, 2005
- Long-Term Effects of Syringe Exchange on Risk Behavior and HIV PreventionAIDS Education and Prevention, 2004
- Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programsJournal of Urban Health, 2000
- Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.American Journal of Public Health, 1995